PrEP Access and Coverage Act of 2023
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The PrEP Access and Coverage Act of 2023 is a health-related bill introduced in the 118th Congress aimed at improving access to and coverage of pre-exposure prophylaxis (PrEP) medications, which are used to prevent HIV infection. The bill was referred to the House Subcommittee on Health but did not advance further and is currently classified as failed or expired. No official summary or full text is available, limiting detailed analysis of its provisions.
This bill sought to enhance access to HIV prevention medication but did not progress beyond initial committee referral and has expired without enactment.
- The bill focuses on improving access and insurance coverage for PrEP medications.
- It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
- The bill did not advance and is currently marked as failed or expired.
['Individuals at risk of HIV infection who could gain improved access to PrEP medications.', 'Healthcare providers involved in prescribing and managing PrEP treatment.', 'Health insurance plans and public health programs potentially impacted by coverage requirements.']
['Lack of available full text and detailed provisions limits assessment of implementation challenges.', 'Potential costs and funding mechanisms for expanding PrEP coverage are not specified.', 'Oversight and enforcement mechanisms related to coverage requirements are unclear.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not advance beyond this stage and is now classified as failed or expired. No further legislative action or debate records are available.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Improved access to PrEP could reduce new HIV infections if implemented, impacting public health outcomes.', 'Changes in insurance coverage requirements might affect healthcare costs and insurance market dynamics.', 'Healthcare providers may need to adjust practices to comply with new coverage or access provisions.']
The absence of the full bill text and official summary limits transparency and public understanding of the bill's detailed provisions and potential impacts. The bill's failure to advance beyond subcommittee referral suggests limited legislative momentum. Oversight and implementation details remain unclear due to missing documentation.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.